| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.2 |